NVAX beat EPS expectations by 306.89%
May 09, 2025, 10:32 PM
0.00%
What does NVAX do
Novavax is a biotechnology company based in Gaithersburg, Maryland, focused on developing recombinant vaccines, including its COVID-19 vaccines Nuvaxovid and other candidates. The company employs 1,543 people and utilizes advanced nanoparticle technology and its Matrix-M adjuvant to enhance immune responses.
Novavax (NVAX) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Novavax's actual EPS was $2.93, beating the estimate of $0.72 per share, resulting in a 306.89% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.